I'm at a loss to know what's happening and as a shareholder I would be very annoyed if they plans are being made without advising the whole market.
Over 6 months have now passed since the release of the PBT IIa trial results and still we're no wiser to it's future plans.
Announcement 28th Nov 2008
"Mr. Kempler confirmed that the Company has entered into confidentiality arrangements with several large pharmaceutical companies and is in various stages of discussion in respect of the licensing of its lead compound PBT2; noting that the positive outcomes from the trial were viewed as a pre-requisite for advancing negotiations with a number of existing parties as well as attracting the interest of new parties."
I would like a market update from the company, in regards to statement above.
market vs industry expectations, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $8.75K | 1.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 63306661 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28430837 | 21 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |